Sysmex Astrego AB
Thanh Nguyen is a researcher at Sysmex Astrego AB since January 2022, with a background in biomedical and medical engineering. Previous experience includes work as a project student at Uppsala University, focusing on the impact of mast cell conditioned medium on melanoma cell growth and optimization of RT-qPCR protocols for SARS-CoV-2 detection. Thanh also served as a medical representative for Servier, providing information on cardiovascular drugs, and as a technical sales assistant for pharmaceutical compounds at Asia Shine Trading and Services Ltd. Early career roles include teaching assistant and laboratory assistant at the University of Medicine and Pharmacy in Ho Chi Minh City, where responsibilities involved instructing students in molecular biology techniques and conducting various laboratory tests. Thanh holds a master's degree in progress at Uppsala University and previously completed an undergraduate degree at the University of Medicine and Pharmacy.
This person is not in any teams
Sysmex Astrego AB
Sysmex Astrego is a rapidly growing in vitro diagnostic company based in Uppsala, Sweden. The company was founded as Astrego Diagnostics in March 2017 and was acquired by Sysmex Corporation, Japan, in May 2022 when the new entity Sysmex Astrego AB was formed. The company name comes from Antibiotic Susceptibility Testing – AST, and rego – being latin for guide, steer or manage. Our mission is to help in the global fight against antimicrobial resistance (AMR) and our products are designed to guide physicians in the selection of effective antibiotic treatments to improve patient outcomes and make antibiotic stewardship easy. Our team combines multidisciplinary scientific excellence with seasoned entrepreneurs and diagnostic industry management.